PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

LinkedIn

Subcutaneous levodopa infusions cut OFF time in advanced Parkinson disease

This systematic review of observational data confirms that continuous subcutaneous levodopa infusions reduce motor fluctuations in advanced Parkinson disease, with infusion-site reactions as the dominant tolerability concern pharmacists must proactively manage.
foslevodopa/foscarbidopaABBV-951VyalevND0612levodopa/carbidopacontinuous subcutaneous infusionParkinson diseasemotor fluctuationsdevice-aided therapysystematic reviewinfusion-site reactions
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report.
Subscribe for Full Access →

Authors: Kiratli Nalbant E, Unlu Acikel S, Ucaryilmaz Ozhamam E, Hayran Y

Citation: Kiratli Nalbant E, Unlu Acikel S, Ucaryilmaz Ozhamam E, et al. A retrospective study of clinical and histopathological characteristics in patients with pityriasis lichenoides: A comparative analysis of pediatric and adult cases. Medicine. 2026;105(27):e49575. doi:10.1097/MD.0000000000049575

Article Links: Journal / DOI · Free Full Text (PMC)

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Suggest a correction Request a topic
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Want the full analysis?

Subscribe to PharmD Signal for unrestricted access to every deep analysis, plus PDF reports, GRADE evidence grades, and pharmacist implications for every article we publish.

Become a Subscriber →